Skip to main content
Clinical Trials/JPRN-UMIN000043321
JPRN-UMIN000043321
Completed
N/A

A clinical study for evaluating the efficacy of test food on the suppression of the elevation of postprandial blood glucose level: Randomized double-blind placebo-controlled trial - A clinical study for evaluating the efficacy of test food on the suppression of the elevation of postprandial blood glucose level

Pharma Foods International Co., Ltd.0 sites30 target enrollmentFebruary 15, 2021
ConditionsHealthy adult

Overview

Phase
N/A
Intervention
Not specified
Conditions
Healthy adult
Sponsor
Pharma Foods International Co., Ltd.
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 15, 2021
End Date
July 31, 2021
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)Subject who is considered as a diabetes by a doctor. 2\)Subject who is taking medication or under medical treatment. 3\)Subject who is under exercise therapy or dietetic therapy. 4\)Subject who has an allergy for test food. 5\)Subject who has or had a history of either medicine or alcohol dependence syndrome. 6\)Subject who has or had a history of mental illness(depression) or sleep disturbance. 7\)Subject who is on a night\-shift or is a shift worker. 8\)Subject whose lifestyle is extremely irregular. 9\)Subject who has an unbalanced diet. 10\)Subject who is current disease or history of brain disorder, cancer, immunity disorder, diabetes, liver disease(hepatitis), kidney disease, serious disease such as heart disease, thyroid disease, adrenal disease, other metabolic diseases. 11\)Subject who is use health foods, supplements, and medicines that may affect diabetes. 12\)Subject who has participated in other clinical studies within the past 3 months from the day of the consent acquisition or who is planning to participate in other clinical studies during the current study. 13\)Subject who has blood drawn 200 mL within the past 1 months or 400 mL within the past 3 months from the day of the consent acquisition. 14\)Subject who is planning to get pregnant after the day of informed consent or is currently pregnant and lactating. 15\)Subject who can't keep the daily records. 16\)Subject who is judged as an inappropriate candidate according to the screening data. 17\)Subject who is considered as an inappropriate candidate by the doctor in charge.

Outcomes

Primary Outcomes

Not specified

Similar Trials